---
schema_version: "secwatch.filing_event.v1"
accession: "0001171843-21-006490"
form_type: "8-K"
ticker: "AGPU"
cik: "0001446159"
company_name: "Axe Compute Inc."
filed_at: "2021-09-15T23:59:59+00:00"
generated_at: "2026-06-29T03:29:09.826695+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Predictive Oncology elects Raymond F. Vennare to Board of Directors

## Summary
- Vennare appointed as Class III Director, term expires at 2021 annual meeting.
- He fills vacancy created by resignation of Richard Gabriel in May 2021.
- Vennare brings 30+ years biotech experience; currently CEO of Cvergenx, Inc.
- Awarded 5,000 restricted shares from Amended 2012 Stock Incentive Plan.

## SEC filing metadata
- accession: 0001171843-21-006490
- form_type: 8-K
- ticker: AGPU
- cik: 0001446159
- company_name: Axe Compute Inc.
- filed_at: 2021-09-15T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1446159/000117184321006490/0001171843-21-006490-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1446159/000117184321006490/f8k_091521.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001171843-21-006490
- JSON: https://secwatch.observer/filing/0001171843-21-006490.json
- Plain text: https://secwatch.observer/filing/0001171843-21-006490.txt

## Key facts
- Executive change
  Raymond F. Vennare was elected as Director at Axe Compute Inc..
  - Action: elected
  - Role: Director
  source text: Effective September 13, 2021, the Board of Directors (“Board”) of Predictive Oncology Inc. (the “Company”) elected Raymond F. Vennare to the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1446159/000117184321006490/0001171843-21-006490-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.